HGH Fragment 176-191 Research# The fragment has been studied primarily as AOD-9604 (an analog with improved stability): Preclinical models : Demonstrated selective fat loss in obese rodent models with 2-3 fold increases in fat oxidation, reduction in adiposity, and glycemic neutrality Phase 2 clinical trial : AOD-9604 was tested in obese adults but did not demonstrate statistically significant weight loss compared to placebo in the primary endpoint analysis Mechanism studies : In vitro data confirm ACC inhibition, HSL activation, and absence of GHR binding Oral formulation : Some studies have explored oral delivery of AOD-9604, representing a departure from the injectable route typical of peptide therapeutics The clinical evidence base is significantly thinner than that of full-length GH, and no regulatory approvals have been granted for the injectable peptide fragment in any major market
99% purity, HPLC verified Certificate of Analysis provided with every batch Precisely blended and quality controlled Secure checkout and fast UK delivery Transparent, research-focused supplier Legal and Safety Information Bluewell Peptides products are supplied strictly for laboratory research and educational purposes only
calorie content (ME calculated) 3,030 kcal/kg, 339 kcal/cup nutrition statement Nulo FreeStyle Adult Trim Cod & Lentils Recipe is formulated to meet the nutritional levels established by the AAFCO Dog Food Nutrient Profiles for maintenance
Some individuals notice increased energy within a few days
